Axa’s Smith & Wesson SWBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-70,800
| Closed | -$923K | – | 1156 |
|
|
2023
Q2 | $923K | Hold |
70,800
| – | – | ﹤0.01% | 851 |
|
|
2023
Q1 | $872K | Buy |
+70,800
| New | +$758K | ﹤0.01% | 886 |
|
|
2022
Q3 | – | Sell |
-10,500
| Closed | -$138K | – | 1202 |
|
|
2022
Q2 | $138K | Hold |
10,500
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q1 | $159K | Hold |
10,500
| – | – | ﹤0.01% | 1163 |
|
|
2021
Q4 | $187K | Sell |
10,500
-80,100
| -88% | -$1.65M | ﹤0.01% | 1122 |
|
|
2021
Q3 | $1.88M | Hold |
90,600
| – | – | 0.01% | 867 |
|
|
2021
Q2 | $3.14M | Sell |
90,600
-30,500
| -25% | -$638K | 0.01% | 800 |
|
|
2021
Q1 | $2.11M | Hold |
121,100
| – | – | 0.01% | 840 |
|
|
2020
Q4 | $2.15M | Buy |
+121,100
| New | +$2M | 0.01% | 839 |
|
|
2020
Q3 | – | Sell |
-54,382
| Closed | -$900K | – | 1350 |
|
|
2020
Q2 | $900K | Sell |
54,382
-49,626
| -48% | -$461K | ﹤0.01% | 972 |
|
|
2020
Q1 | $664K | Sell |
104,008
-129,391
| -55% | -$916K | ﹤0.01% | 925 |
|
|
2019
Q4 | $1.67M | Hold |
233,399
| – | – | 0.01% | 829 |
|
|
2019
Q3 | $1.05M | Buy |
+233,399
| New | +$1.41M | ﹤0.01% | 977 |
|
|
2017
Q2 | – | Sell |
-26,150
| Closed | -$398K | – | 1298 |
|
|
2017
Q1 | $398K | Sell |
26,150
-207,510
| -89% | -$3.16M | ﹤0.01% | 1116 |
|
|
2016
Q4 | $3.79M | Buy |
233,660
+29,143
| +14% | +$538K | 0.02% | 635 |
|
|
2016
Q3 | $4.18M | Sell |
204,517
-12,880
| -6% | -$282K | 0.02% | 602 |
|
|
2016
Q2 | $4.54M | Buy |
217,397
+29,663
| +16% | +$530K | 0.02% | 584 |
|
|
2016
Q1 | $3.84M | Sell |
187,734
-12,100
| -6% | -$225K | 0.02% | 624 |
|
|
2015
Q4 | $3.38M | Sell |
199,834
-2,081
| -1% | -$30.6K | 0.01% | 662 |
|
|
2015
Q3 | $2.62M | Buy |
201,915
+32,265
| +19% | +$421K | 0.01% | 728 |
|
|
2015
Q2 | $2.16M | Buy |
+169,650
| New | +$1.96M | 0.01% | 777 |
|
|
2014
Q4 | – | Sell |
-114,358
| Closed | -$830K | – | 1476 |
|
|
2014
Q3 | $830K | Hold |
114,358
| – | – | ﹤0.01% | 953 |
|
|
2014
Q2 | $1.28M | Hold |
114,358
| – | – | 0.01% | 872 |
|
|
2014
Q1 | $1.28M | Buy |
114,358
+1,431
| +1% | +$14.7K | 0.01% | 878 |
|
|
2013
Q4 | $1.17M | Buy |
112,927
+49,828
| +79% | +$445K | 0.01% | 886 |
|
|
2013
Q3 | $533K | Hold |
63,099
| – | – | ﹤0.01% | 990 |
|
|
2013
Q2 | $484K | Buy |
+63,099
| New | +$439K | ﹤0.01% | 974 |
|
Other funds holding SWBI
PCM
Axa's SWBI Position: Q3 2023 in Review
Axa sold out of Smith & Wesson (SWBI) in Q3 2023, closing a stake of 70,800 shares — an estimated $923K sold.
Axa first reported a position in SWBI in Q2 2013 and held it in 27 quarters. The position peaked at $4.54M in Q2 2016. 169 funds tracked by Wall St. Rank hold SWBI as of Q3 2023.
- Axa reported no remaining Smith & Wesson position as of Q3 2023 after selling out during the quarter.
- Axa sold 70,800 Smith & Wesson shares in Q3 2023, an estimated $923K.
- Axa first reported a position in Smith & Wesson in Q2 2013 and held it in 27 quarters.
- Axa's Smith & Wesson position peaked at $4.54M in Q2 2016.
- 169 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2023.
Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.